250 related articles for article (PubMed ID: 37830387)
1. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
[TBL] [Abstract][Full Text] [Related]
2. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
3. Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.
Nag S; Bhattacharya B; Dutta S; Mandal D; Mukherjee S; Anand K; Eswaramoorthy R; Thorat N; Jha SK; Gorai S
ACS Biomater Sci Eng; 2023 Sep; 9(9):5205-5221. PubMed ID: 37578350
[TBL] [Abstract][Full Text] [Related]
4. Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes.
Xiong J; Chi H; Yang G; Zhao S; Zhang J; Tran LJ; Xia Z; Yang F; Tian G
Front Immunol; 2023; 14():1188760. PubMed ID: 37342327
[TBL] [Abstract][Full Text] [Related]
5. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer.
Hánělová K; Raudenská M; Masařík M; Balvan J
Cell Commun Signal; 2024 Jan; 22(1):25. PubMed ID: 38200509
[TBL] [Abstract][Full Text] [Related]
6. Exosomes: Critical Mediators of Tumour Microenvironment Reprogramming.
Malla RR; Shailender G; Kamal MA
Curr Med Chem; 2021; 28(39):8182-8202. PubMed ID: 33334279
[TBL] [Abstract][Full Text] [Related]
7. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication.
Huang Y; Kanada M; Ye J; Deng Y; He Q; Lei Z; Chen Y; Li Y; Qin P; Zhang J; Wei J
Cancer Lett; 2022 Sep; 543():215796. PubMed ID: 35728740
[TBL] [Abstract][Full Text] [Related]
9. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
[TBL] [Abstract][Full Text] [Related]
10. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
11. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
Wu Q; Zhou L; Lv D; Zhu X; Tang H
J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
[TBL] [Abstract][Full Text] [Related]
13. Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications.
Ye H; Hu X; Wen Y; Tu C; Hornicek F; Duan Z; Min L
J Nanobiotechnology; 2022 Sep; 20(1):403. PubMed ID: 36064358
[TBL] [Abstract][Full Text] [Related]
14. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
Achreja A; Zhao H; Yang L; Yun TH; Marini J; Nagrath D
Metab Eng; 2017 Sep; 43(Pt B):156-172. PubMed ID: 28087332
[TBL] [Abstract][Full Text] [Related]
15. Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells.
Rubenich DS; Omizzollo N; Szczepański MJ; Reichert TE; Whiteside TL; Ludwig N; Braganhol E
Cytokine Growth Factor Rev; 2021 Oct; 61():16-26. PubMed ID: 34479816
[TBL] [Abstract][Full Text] [Related]
16. Exosomes as a modulator of immune resistance in human cancers.
Li L; Wang C; Li Q; Guan Y; Zhang X; Kong F; Feng Z; Lu Y; Wang D; Wang N
Cytokine Growth Factor Rev; 2023 Oct; 73():135-149. PubMed ID: 37543438
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNAs in the microenvironment of pancreatic cancer.
Zou X; Huang Z; Guan C; Shi W; Gao J; Wang J; Cui Y; Wang M; Xu Y; Zhong X
Clin Chim Acta; 2023 Apr; 544():117360. PubMed ID: 37086943
[TBL] [Abstract][Full Text] [Related]
18. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
[TBL] [Abstract][Full Text] [Related]
19. Immunocyte Derived Exosomes: Insight into the Potential Chemo-immunotherapeutic Nanocarrier Targeting the Tumor Microenvironment.
Basak M; Chaudhary DK; Takahashi RU; Yamamoto Y; Tiwari S; Tahara H; Mittal A
ACS Biomater Sci Eng; 2023 Jan; 9(1):20-39. PubMed ID: 36524837
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
